IAI FigSearch
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Faruque, S. M.
Right arrow Articles by Mekalanos, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Faruque, S. M.
Right arrow Articles by Mekalanos, J. J.

 Previous Article  |  Next Article 

Infect Immun, August 1998, p. 3752-3757, Vol. 66, No. 8
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Induction of the Lysogenic Phage Encoding Cholera Toxin in Naturally Occurring Strains of Toxigenic Vibrio cholerae O1 and O139

Shah M. Faruque,1 * Asadulghani,1 A. R. M. Abdul Alim,1 M. John Albert,1 K. M. Nasirul Islam,1 and John J. Mekalanos2

Molecular Genetics Laboratory, International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka-1000, Bangladesh,1 and Department of Microbiology and Molecular Genetics, Harvard Medical School, Boston, Massachusetts 021152

Received 19 February 1998/Returned for modification 15 April 1998/Accepted 5 May 1998

    ABSTRACT
Top
Abstract
Introduction
Materials & Methods
Results & Discussion
References

In toxigenic Vibrio cholerae, the CTX genetic element which carries the genes for cholera toxin (CT) is the genome of a lysogenic bacteriophage (CTXPhi ). Clinical and environmental strains of V. cholerae O1 or O139 and stools that were culture positive for cholera were analyzed to study the induction and transmission of CTXPhi . To our knowledge, this is the first report of the examination of CTXPhi in clinical materials and in naturally occurring strains. DNA probe analysis revealed that 4.25% (6 of 141) of the isolated V. cholerae strains spontaneously produced a detectable level of extracellular CTXPhi particles in the culture supernatants whereas another 34.04% (48 of 141) produced CTXPhi particles when induced with mitomycin C. CTXPhi isolated from 10 clinical or environmental strains infected a CT-negative recipient strain, CVD103, both inside the intestines of infant mice and under laboratory conditions. All culture-positive stools analyzed were negative for the presence of CTXPhi both in the DNA probe assay and by in vivo assay for the infection of the recipient strain in infant mice. These results suggested that naturally occurring strains of toxigenic V. cholerae are inducible lysogens of CTXPhi but that cholera pathogenesis in humans is not associated with the excretion of CTXPhi particles in stools, indicating that induction of the phage may not occur efficiently inside the human intestine. However, in view of the efficient transmission of the phage under conditions conducive to the expression of toxin-coregulated pili, it appears that propagation of CTXPhi in the natural habitat may involve both environmental and host factors.

    INTRODUCTION
Top
Abstract
Introduction
Materials & Methods
Results & Discussion
References

Cholera caused by toxigenic Vibrio cholerae is a major public health problem in developing countries. Epidemiological surveillance of cholera and comparative molecular analysis of strains collected during outbreaks have demonstrated clonal diversity among epidemic strains and a continual emergence of new clones of toxigenic V. cholerae (5-7, 21). The mechanisms involved in the emergence of new toxigenic clones have not been adequately explained, although it is assumed that a combination of genetic changes and natural selection caused by unidentified environmental factors as well as the immune status of the host populations is likely to influence the process.

The profuse secretory diarrhea characteristic of cholera is caused by an enterotoxin, cholera toxin (CT), produced by toxigenic V. cholerae when it colonizes the small intestine (20). The genes encoding CT (ctxAB) are part of a larger genetic element (CTX genetic element) consisting of at least six genes (ctxAB, zot, ace, cep, and orfU) comprising the "core" region that is flanked by two or more copies of a repeated sequence (19, 23). It has been demonstrated recently (24) that in the V. cholerae O1 strain P27459 (genetically modified by marker exchange and renamed SM44), the entire CTX element constituted the genome of a filamentous bacteriophage (CTXPhi ). The phage could be propagated in recipient V. cholerae strains in which the CTXPhi genome either integrated chromosomally at a specific site, forming stable lysogens, or was maintained extrachromosomally as a replicative form (RF) of the phage DNA (24). Cultures of V. cholerae harboring the RF of CTXPhi produced high titers of the phage in their supernatants. This study indicated that the propagation of CTXPhi may be associated with horizontal gene transfer leading to the origination of novel toxigenic strains of V. cholerae. More recently, it has been reported that during passage of CTXPhi lysogens through the infant-mouse intestine, phage excision and replication occur in vivo (16). The present study was undertaken to analyze the induction of lysogenic CTXPhi in clinical and environmental isolates of toxigenic V. cholerae and to investigate whether cholera pathogenesis in humans is associated with the excretion of CTXPhi particles in the stools. Furthermore, this study investigated the ability of CTXPhi particles derived from naturally occurring V. cholerae strains to infect a CT-negative recipient strain of V. cholerae O1 inside the gastrointestinal tracts of infant mice and under laboratory conditions.

    MATERIALS AND METHODS
Top
Abstract
Introduction
Materials & Methods
Results & Discussion
References

V. cholerae strains and cholera stools. Toxigenic V. cholerae strains analyzed in this study to investigate the induction of lysogenic CTXPhi included a total of 125 clinical isolates and 16 environmental isolates belonging to O1 or O139 serogroups. Clinical isolates and stools that were culture positive for cholera were obtained from patients who attended the treatment center of the International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B) located in Dhaka. The clinical strains consisted of 78 strains from the culture collection of ICDDR,B (Table 1) and 47 strains isolated from freshly collected culture-positive stools, which were also analyzed in this study (Table 2). The environmental strains were obtained from surface waters in Dhaka. Strains were stored either in lyophilized form or in sealed deep nutrient agar at room temperature. Before use, the identities of the V. cholerae cultures were confirmed by biochemical reactions and serological test (27), and the presence of the CTX element was ascertained by using DNA probes (6). The relevant characteristics of V. cholerae strains used as controls or as a recipient of CTXPhi are listed in Table 3.

                              
View this table:
[in this window]
[in a new window]
 
TABLE 1.   Analysis of toxigenic V. cholerae O1 and O139 strains isolated between 1969 and 1997 in Bangladesh for the induction of CTXPhi

                              
View this table:
[in this window]
[in a new window]
 
TABLE 2.   Analysis of 47 culture-positive stools collected during June and July 1997 in Bangladesh for the presence of cell-free CTXPhi a

                              
View this table:
[in this window]
[in a new window]
 
TABLE 3.   Characteristics of V. cholerae O1 reference strains used in this study

Probes and hybridization. The gene probes used in this study to detect the CTXPhi genome were a 0.5-kb EcoRI fragment of pCVD27 (14), containing part of the ctxA gene, and an 840-bp region internal to the zot gene amplified by PCR from the recombinant plasmid pBB241 as described previously (8). Strand-specific oligonucleotide probes with the sequences 5'-TCTATCTCTGTAGCCCCTATTACG and 5'-CTCAGACGGGATTTGTTAGGCACG for probing the plus and minus strands, respectively, were also used to detect the presence of single-stranded DNA of CTXPhi . Colony blots or Southern blots were prepared with nylon filters (Hybond; Amersham International plc., Ayelesbury, United Kingdom) and processed by standard methods (17). The polynucleotide probes were labeled by random priming (10) with a random-primer DNA-labeling kit (Bethesda Research Laboratories, Gaithersburg, Md.) and [alpha -32P]dCTP (3,000 Ci/mmol; Amersham), and oligonucleotide probes were labeled by 3' tailing with terminal deoxynucleotide transferase and [alpha -32P]dCTP. Southern blots and colony blots were hybridized with the labeled probes and autoradiographed as described by us previously (5-7).

Induction of CTXPhi lysogens. Toxigenic V. cholerae strains were grown in Luria broth (LB) at 30°C to an absorbance at 540 nm of 0.2. The cells were collected by centrifugation, washed, and resuspended in fresh LB. The suspension was divided into aliquots, to which mitomycin C (Sigma Chemical Co., St. Louis, Mo.) was added at 20 ng/ml and incubated overnight at 30°C. The culture supernatants were analyzed for extracellular phage carrying the CTX element as described in the following section. Strains grown in a similar way but without mitomycin C were used as controls.

Screening of stools and bacterial cultures for CTXPhi . Freshly collected culture-positive stools and V. cholerae strains either isolated from the same stools (Table 2) or obtained from the culture collection (Table 1) were used. Aliquots of watery stools or cultures were centrifuged at 6,000 × g to precipitate solid particles and suspended bacteria, and the supernatants were sterilized by filtration through 0.22-µm-pore-size filters (Millipore Corp., Bedford, Mass.). To confirm that the filtrates from stools as well as the culture supernatants did not contain any bacterial cell, aliquots of the filtrates were streaked on Luria agar (LA) plates and incubated overnight at 37°C. The sterile filtrates were mixed with one-fourth volumes of a solution containing 20% polyethylene glycol 6000 and 10% NaCl and centrifuged at 12,000 × g to precipitate the phage particles. The precipitate was dissolved in a solution containing 20 mM Tris-Cl (pH 7.5), 60 mM KCl, 10 mM MgCl, and 10 mM NaCl and digested with pancreatic DNase I (100 U/ml) and RNase A (50 µg/ml) at 37°C for 1 h to remove possible nucleic acids carried over from lysed bacterial cells. The solution was extracted with phenol-chloroform to disrupt possible phage particles, and the total nucleic acids were precipitated with ethanol. Preparations containing CTXPhi DNA were identified by Southern blot hybridization (22). Aliquots of watery stools mixed with serial dilutions of CTX-KmPhi (101 to 104 particles/ml) isolated from a mitomycin C-induced culture of strain SM44 were used as positive controls for the assay of phage in stools, for both in vitro and in vivo assays. CTX-KmPhi derived from SM44 was quantified by incubating serially diluted filter-sterilized culture supernatants with strain RV508 and then determining the number of Kmr colonies, as described previously (24).

The infectious activity of possible CTXPhi present in the cell-free culture supernatants of toxigenic V. cholerae strains and extracts of culture-positive stools was assayed with strain CVD103 (15) as the recipient in vivo in suckling mice and in vitro under laboratory conditions as follows. Aliquots (10 ml) of filtered sterile supernatant fluids from mitomycin C-induced cultures or control cultures without mitomycin C or filtered stool extracts were used to precipitate phage particles. The pellet was suspended in 100 µl of TES buffer (20 mM Tris-HCl [pH 7.5], 10 mM NaCl, 0.1 mM disodium EDTA). The recipient strain was grown in LB at 37°C; the cells were precipitated by centrifugation and washed in fresh LB. Approximately 105 bacterial cells mixed with 10 µl of the phage preparation in a final volume of 50 µl were gastrointestinally inoculated into groups of 5-day-old Swiss Albino mice obtained from the breeding facilities of the Animal Resources Branch, ICDDR,B. For each phage preparation, at least five mice were inoculated. The animals were sacrificed after 24 h, and their intestines were removed and homogenized in 10 mM phosphate-buffered saline (pH 7.2). The homogenate was centrifuged at low speed to precipitate debris, the supernatant was then centrifuged to precipitate bacterial cells, and the pellet was resuspended in phosphate-buffered saline. Serial dilutions of an aliquot of the suspension were plated on taurocholate-tellurite-gelatin agar (18) to select V. cholerae colonies. All the colonies were screened for the presence of the CTXPhi genome by using the ctxA or zot probe. The ratio of probe-positive colonies to total colonies recovered was calculated and expressed as the percentage of recipient cells carrying the CTXPhi genome (Table 4). For in vitro assays, mixtures of phage and recipient cells as described above were prepared. Each mixture was inoculated into 5 ml of LB and incubated for 1 h at 30°C, and aliquots of the culture were plated on LA plates and incubated overnight at 30°C. For each strain and phage combination, five different in vitro assays were performed and at least 104 colonies of the recipient strain recovered from each of these assays were screened for the CTXPhi genome.

                              
View this table:
[in this window]
[in a new window]
 
TABLE 4.   Infection of strain CVD103 by extracellular CTXPhi isolated from the supernatant fluids of mitomycin C-induced cultures of clinical and environmental V. cholerae strains

Representative probe-positive colonies of the recipient strain were further analyzed for the presence and integration of the phage genome. Total DNA or plasmid was extracted by standard methods (17), purified with microcentrifuge filter units (Ultrafree-Probind; Sigma), and analyzed by Southern blot hybridization. To test the stability of the CTXPhi genome in infected cells, representative probe-positive colonies of the infected recipient strain CVD103 were grown at 37°C in LB for several generations (6 to 24 h) and were tested for the presence of the CTX element by colony blot hybridization. Similarly, a colony of CVD103 infected with CTX-KmPhi derived from strain SM44 was grown for 6 to 24 h in aliquots of LB either containing kanamycin (50 µg/ml) or without kanamycin. Serial dilutions of the cultures were plated on LA plates containing kanamycin and on a duplicate set of LA plates devoid of the antibiotic to determine the proportion of cells retaining the phage genome.

    RESULTS AND DISCUSSION
Top
Abstract
Introduction
Materials & Methods
Results & Discussion
References

Induction and transmission of CTXPhi . To investigate whether lysogenic CTXPhi present in toxigenic V. cholerae strains could be induced to produce extracellular infectious phage particles, we cultured the strains in the presence of a DNA-damaging agent, mitomycin C, and then screened the culture supernatant fluids for the presence of CTXPhi by using DNA probes. Similarly, freshly collected culture-positive stools were analyzed for the presence of CTXPhi to understand whether the phage is excreted in the stools of cholera patients. Another strategy for detecting the presence of infectious CTXPhi in culture supernatants as well as in culture-positive stools was to expose a suitable recipient strain, CVD103, to the phage preparations and then look for infection of the bacterial cells. None of the culture-positive stools analyzed was positive for the presence of a detectable level of CTXPhi either in the DNA probe assay or in the in vivo assay in infant mice. To determine the detection limits of our assays, we used reconstituted stools containing a known number of phage particles. This was done by using a genetically marked phage, CTX-KmPhi (derived from strain SM44), since CTX-KmPhi could be quantified by titration with a recipient strain RV508, which constitutively expresses toxin-coregulated pili (TCP) and hence is readily infected by the phage (24). In the case of stools mixed with exogenous CTX-KmPhi and used as positive controls, a minimum of 103 phage particles in 5 ml of stool could be distinctly detected by Southern blot hybridization (Fig. 1). When assayed in infant mice, the presence of 102 particles of CTX-KmPhi in 5 ml of reconstituted stools could be detected and the corresponding stool extract produced between one and nine colonies (recovered from five different mice) of Kmr transductants of CVD103.


View larger version (87K):
[in this window]
[in a new window]
 
FIG. 1.   Southern blot hybridization of bacteriophage DNA isolated from reconstituted culture-positive stools containing serial dilutions of the genetically marked phage CTX-KmPhi and probed with the zot probe. Lanes 1 through 7 correspond to extracts from 5 ml of stools containing 1 × 102, 5 × 102, 1 × 103, 1.5 × 103, 2 × 103, 2.5 × 103, and 5 × 103 phage particles, respectively. Numbers indicating the molecular sizes of bands correspond to the supercoiled DNA ladder (Bethesda Research Laboratories).

Of a total of 141 V. cholerae strains obtained from the culture collection and from fresh culture-positive stools, 6 strains spontaneously produced a low but detectable level of extracellular CTXPhi whereas another 48 strains (34.04%) produced extracellular CTXPhi when induced with mitomycin C, as shown by Southern blot hybridization (Fig. 2). These 54 strains included 12 strains isolated from fresh culture-positive stools which tested negative for the presence of CTXPhi . Strains that produced extracellular CTXPhi included 7 (19.44%) of 36 El Tor strains and 5 (45.45%) of 11 O139 strains obtained from freshly collected stools and 22 (43.13%) of 51 El Tor strains and 20 (46.51%) of 43 O139 strains analyzed from previous collections (Tables 1 and 2). As expected for a filamentous phage, Southern blot hybridization with strand-specific oligonucleotide probes revealed that the phage DNA was single stranded and hybridized with the probe specific for the plus strand but not with the probe for the corresponding minus strand. The bands corresponding to the CTXPhi DNA were not clearly visible on ethidium bromide-stained agarose gels (data not shown) but could be detected distinctly by hybridization of the Southern blots with the specific probes (Fig. 2).


View larger version (82K):
[in this window]
[in a new window]
 
FIG. 2.   Supernatant fluids of toxigenic V. cholerae O1 or O139 strains grown in the presence of mitomycin C (20 ng/ml) were sterilized by filtration through a 0.22-µm filter and were used to precipitate possible bacteriophage particles. The precipitates were dissolved in appropriate buffer and treated with DNase I and RNase A to remove contaminating exogenous DNA or RNA. Total phage nucleic acids were isolated as described in Materials and Methods and analyzed with the ctxA probe. Southern blot hybridization analyses of total phage nucleic acids derived from six different V. cholerae strains (indicated by strain numbers) are shown. Numbers indicating the molecular sizes of bands correspond to supercoiled DNA ladder (Bethesda Research Laboratories).

It has been shown previously that most of the genes in the core region of the CTXPhi genome play a crucial role in the morphogenesis of the phage (24). The reasons for the apparent inability of 87 of the 141 strains to produce CTXPhi particles on induction with mitomycin C (Table 1) may be that the integrated form of CTXPhi carried by these strains is defective due to possible mutations in one or more genes essential for phage morphogenesis. Strains analyzed in this study included both V. cholerae O1 and O139 carrying variable number of copies of the CTX element, and a difference was noted in terms of induction of CTXPhi in strains belonging to these serogroups. The phage was more often inducible in O139 strains (46.29%) than in El Tor strains (33.33%). Generally, O139 strains are known to carry more than one copy of the CTX element (9, 25), and this may account for the higher prevalence of inducible lysogens among O139 vibrios. In the present study, CTXPhi was induced by the DNA-damaging agent mytomycin C, which is known to induce many temperate bacteriophages. However, six strains including two environmental strains produced a detectable level of extracellular CTXPhi particles, even without treatment with mitomycin C (Table 1), indicating that unidentified environmental factors or possible mutations in the phage or the host bacteria might have caused induction of the CTXPhi in these strains. Further studies are required to define possible factors which may play a role in the induction of lysogenic CTXPhi in toxigenic V. cholerae in the natural habitat.

We used two different methods to determine the presence of infectious phage particles in culture supernatants or culture-positive stools. These included an in vitro laboratory method and the infant-mouse system, both of which have been previously described (24). However, in previous studies (16, 24), the transmission of CTXPhi was examined between a recipient strain and a donor strain of V. cholerae when the strains were grown in mixed culture or inoculated into infant mice, whereas in the present study cell-free phage particles were used to infect the recipient strain. In addition to adequate expression of TCP, which is the receptor for the phage, the infant-mouse system is known to cause significant enrichment of toxigenic V. cholerae strains (2). Hence, the infant-mouse assay was expected to detect the presence of a smaller number of infectious phage particles in the samples. On the other hand, the in vitro method was also chosen because, from the ecological perspective, it is important to understand the ability of CTXPhi to propagate independently of the mammalian host, in view of the possibility that propagation of CTXPhi in the natural habitat is associated with the origination of new toxigenic strains through lysogenic conversion (24).

The use of CVD103, which is a derivative of the V. cholerae O1 classical strain 569B with ctxA deleted, provided certain obvious advantages. Since CVD103 is a classical biotype strain, it was supposed to be more susceptible to CTXPhi than are El Tor strains, as described previously (24), and hence was expected to facilitate the detection of CTXPhi . Due to deletion of the ctxA gene, CVD103 would not hybridize with the ctxA probe which was used in colony blot hybridization to detect colonies infected by wild-type CTXPhi . Moreover, since CVD103 is a vaccine prototype strain, its use provided an opportunity to study the susceptibility of an attenuated vaccine strain to CTXPhi .

In the present study, strain CVD103 was infected by CTXPhi both under in vitro laboratory conditions and inside the intestines of infant mice (Table 4). The infant-mouse assay, which detected the presence of 102 CTX-KmPhi particles in 5 ml of reconstituted stool, was approximately 50 times more sensitive than the Southern hybridization assay, which detected 103 phage particles, since only one-fifth of the stool extract (10 µl of 50 µl of total extract) was used for each assay in mice. The high sensitivity of the assay in infant mice for both reconstituted stools and culture supernatants could also be due to the prolonged incubation of infected cells carrying the RF of CTXPhi inside the mouse intestine, leading to production of a larger number of infectious phage particles, in addition to adequate expression of TCP in vivo. It should be clarified that this study was not designed to compare the susceptibility of the recipient strain to CTXPhi in vivo and in vitro. Instead, we have successfully used the infant-mouse model in an assay to detect the presence of infectious CTXPhi in culture supernatants and clinical specimens. In addition, the observed ability of wild-type CTXPhi to transmit its genome into the vaccine prototype strain CVD103 suggested that there is a need to modify and redesign possible live vaccine candidates in view of the possible reacquisition of CT genes by attenuated strains.

Stability of the CTXPhi genome in the recipient strain. CTXPhi is unusual among filamentous phages because it can either replicate as a plasmid or integrate into the V. cholerae chromosome at a specific attachment site (24). Analysis of representative probe-positive colonies for the presence of CTXPhi genome revealed the presence of the RF of the CTXPhi genome in freshly infected colonies. However, the concentration of the RF DNA was too low to be visible in ethidium bromide-stained gels, but it could be faintly detected by Southern blot hybridization (data not shown). The phage genome was rapidly lost from infected cells when the infected cells were cultured under laboratory conditions, and only 0.9% of the colonies recovered after 24 h of culture hybridized with the ctxA probe. The CTXPhi genome did not integrate into the chromosome of CVD103, as shown by Southern blot analysis of genomic DNA with the ctxA probe (data not shown) as well as presumed from the rapid loss of CTXPhi genome from infected cells. When CVD103 was infected with CTX-KmPhi derived from strain SM44, the infected cells retained the RF of the phage when cells were grown in the presence of kanamycin. However, when the infected cells were cultured in the absence of kanamycin, the RF of CTX-KmPhi was rapidly lost and 60.3% of viable cells recovered after 12 h of culture became susceptible to kanamycin (50 µg/ml). Previously, the CTXPhi genome was shown to integrate into the chromosome when an El Tor strain carrying a resident attRS sequence was used as the recipient (24). In the previous study, the phage was marked with kanamycin resistance and the transfectants were maintained in the presence of kanamycin. Similarly, in the present study, CVD103 cells infected with the CTX-KmPhi retained the RF DNA of the phage when the cells were grown in the presence of kanamycin but rapidly lost the RF of CTX-KmPhi in the absence of kanamycin. This indicated that there was a requirement for appropriate selection pressure for the retention of the extrachromosomal CTX element in V. cholerae. The lack of selection of cells carrying the RF of CTXPhi could account for the subsequent loss of the phage DNA. However, once the phage genome integrates into the chromosome of the recipient cell, it is likely to be more stable. There have been several studies which suggested that the gastrointestinal environment can cause a selective enrichment of toxigenic V. cholerae strains compared to nontoxigenic strains (2, 11, 13). It therefore seems possible that in addition to adequate expression of TCP, which is the receptor for the phage, the intestinal environment also contributes to selecting V. cholerae cells harboring the CTXPhi genome. Since the CTX element itself carries the necessary genes for its own integration at resident attRS sites of the host chromosome (26), the origination of novel toxigenic strains of V. cholerae and their selective enrichment are likely to occur in the intestinal environment.

Propagation of CTXPhi . The existence of CTXPhi was discovered by using a genetically modified V. cholerae strain, SM44, in which the CTX element was marked with a kanamycin resistance (Kmr) determinant (12, 24). The presence of the Kmr marker facilitated the detection of the induction and transmission of the phage. The present study has investigated for the first time the prevalence of inducible lysogens of CTXPhi among naturally occurring strains of toxigenic V. cholerae and the potential of the extracellular phage particles to infect a CT-negative recipient strain of V. cholerae. This study is also the first to examine clinical materials for the presence of CTXPhi and to investigate whether cholera pathogenesis is normally associated with the excretion of the phage in stools. Since the CTX element was not marked with a phenotypically detectable marker in native strains, detection of the induction of CTXPhi and its transmission in vitro and in infant mice were studied with specific DNA probes. Although V. cholerae is known to be primarily a human pathogen, it has been suggested that the bacterium can persist in the aquatic environment in unexplained ecological associations (3). The natural habitat of toxigenic V. cholerae therefore seems to consist of two compartments: the gastrointestinal tract of the host and the aquatic environment outside the host. The host compartment is known to provide signals necessary for the expression of most ToxR-regulated virulence-associated factors, including CT and TCP (1, 4). To investigate whether induction of the CTXPhi prophage is also mediated by possible host factors in the human gastrointestinal tract, we screened culture-positive stools for the presence of the phage. That all the stools were negative for the phage suggested that induction of lysogenic CTXPhi was possibly not associated with cholera pathogenesis in humans, unless we assume that the CTXPhi particles were very unstable in the human intestine and rapidly degraded beyond the detection limit of our assays. However, the present study showed that when extracellular CTXPhi isolated from naturally occurring strains and the control strain SM44 were used to infect the recipient strain in vivo, CTXPhi particles were stable and remained infectious in the gastrointestinal environment of infant mice. It may be mentioned that induction of the CTXPhi prophage in infant mice has been reported recently based on observed transduction of a recipient strain by a CTXPhi lysogen inside the intestines of infant mice (16). The present study, however, did not provide any evidence in favor of the induction of lysogenic CTXPhi inside the human intestine in association with cholera pathogenesis.

The propagation of CTXPhi in its natural habitat is likely to involve the excision and replication of the lysogenic phage followed by infection of recipient V. cholerae strains, possibly mediated by appropriate signals in the host intestine. Since the present study did not provide any conclusive evidence to suggest that the induction of the phage occurs inside the intestine of the human host, we speculate that induction of CTXPhi in naturally occurring strains of toxigenic V. cholerae may also occur in the environmental habitat. Our efforts are at present directed toward understanding the role of possible environmental factors in the induction and propagation of the CTX phage.

    ACKNOWLEDGMENTS

This research was funded by the U.S. Agency for International Development (USAID) under grant HRN-5986-A-00-6005-00 with the International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B). The ICDDR,B is supported by countries and agencies which share its concern for the health problems in developing countries.

    FOOTNOTES

* Corresponding author. Mailing address: Molecular Genetics Laboratory, Laboratory Sciences Division, ICDDR,B. G.P.O. Box 128, Dhaka-1000, Bangladesh. Phone: 880 2 871760. Fax: 880 2 872529 and 880 2 883116. E-mail: faruque{at}icddrb.org.

Editor:  J. T. Barbieri

    REFERENCES
Top
Abstract
Introduction
Materials & Methods
Results & Discussion
References

1. Baselski, V., R. Briggs, and C. Parker. 1977. Intestinal fluid accumulation induced by oral challenge with Vibrio cholerae or cholera toxin in infant mice. Infect. Immun. 15:704-712[Abstract/Free Full Text].
2. Baselski, V. S., R. A. Medina, and C. D. Parker. 1979. In vivo and in vitro characterization of virulence-deficient mutants of Vibrio cholerae. Infect. Immun. 24:111-116[Abstract/Free Full Text].
3. Colwell, R. R., and W. M. Spira. 1992. The ecology of Vibrio cholerae, p. 107-127. In D. Barua, and W. B. Greenough III (ed.), Cholera. Plenum Medical Book Co., New York, N.Y.
4. DiRita, V. J. 1992. Co-ordinate expression of virulence genes by ToxR in Vibrio cholerae. Mol. Microbiol. 6:451-458[Medline].
5. Faruque, S. M., S. K. Roy, A. R. M. A. Alim, A. K. Siddique, and M. J. Albert. 1995. Molecular epidemiology of toxigenic Vibrio cholerae in Bangladesh studied by numerical analysis of rRNA gene restriction patterns. J. Clin. Microbiol. 33:2833-2838[Abstract].
6. Faruque, S. M., K. M. Ahmed, A. R. M. A. Alim, F. Qadri, A. K. Siddique, and M. J. Albert. 1997. Emergence of a new clone of toxigenic Vibrio cholerae biotype El Tor displacing V. cholerae O139 Bengal in Bangladesh. J. Clin. Microbiol. 35:624-630[Abstract].
7. Faruque, S. M., K. M. Ahmed, A. K. Siddique, K. Zaman, A. R. M. A. Alim, and M. J. Albert. 1997. Molecular analysis of toxigenic Vibrio cholerae O139 Bengal strains isolated in Bangladesh between 1993 and 1996: evidence for the emergence of a new clone of the Bengal vibrios. J. Clin. Microbiol. 35:2299-2306[Abstract].
8. Faruque, S. M., L. Comstock, J. B. Kaper, and M. J. Albert. 1994. Distribution of zonula occludens toxin (zot) gene among clinical isolates of Vibrio cholerae O1 from Bangladesh and Africa. J. Diarrhoeal Dis. Res. 12:222-224[Medline].
9. Faruque, S. M., A. R. M. A. Alim, S. K. Roy, F. Khan, G. B. Nair, R. B. Sack, and M. J. Albert. 1994. Molecular analysis of rRNA and cholera toxin genes carried by the new epidemic strain of toxigenic Vibrio cholerae O139 synonym Bengal. J. Clin. Microbiol. 32:1050-1053[Abstract/Free Full Text].
10. Feinberg, A., and B. Volgelstein. 1984. A technique for radio labeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 137:266-267[Medline].
11. Finkelstein, R. A., M. L. Vasil, and R. K. Holmes. 1974. Studies on toxinogenesis in Vibrio cholerae. I. Isolation of mutants with altered toxinogenicity. J. Infect. Dis. 129:117-123[Medline].
12. Goldberg, I., and J. J. Mekalanos. 1986. Effect of a recA mutation on cholera toxin gene amplification and deletion events. J. Bacteriol. 165:723-731[Abstract/Free Full Text].
13. Holmes, R. K., M. L. Vasil, and R. A. Finkelstein. 1975. Studies on toxino-genesis in Vibrio cholerae. III. Characterization of nontoxigenic mutants in vitro and in experimental animals. J. Clin. Invest. 55:551-556.
14. Kaper, J. B., J. G. Morris, Jr., and M. Nishibuchi. 1988. DNA probes for pathogenic Vibrio species, p. 65-67. In F. C. Tenover (ed.), DNA probes for infectious diseases. CRC Press, Inc., Boca Raton, Fla.
15. Ketly, J. M., J. Michalski, J. Galen, M. M. Levine, and J. B. Kaper. 1993. Construction of genetically-marked Vibrio cholerae O1 vaccine strains. FEMS Microbiol. Lett. 111:15-22[Medline].
16. Lazar, S., and M. K. Waldor. 1998. ToxR-independent expression of cholera toxin from the replicative form of CTXPhi . Infect. Immun. 66:394-397[Abstract/Free Full Text].
17. Maniatis, T., E. F. Fritsch, and J. Sambrook. 1982. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
18. Monsur, K. A. 1961. A highly selective gelatine-taurocholate tellurite medium for the isolation of Vibrio cholerae. Trans. R. Soc. Trop. Med. Hyg. 55:440-442[Medline].
19. Pearson, G. D. N., A. Woods, S. L. Chiang, and J. J. Mekalanos. 1993. CTX genetic element encodes a site-specific recombination system and an intestinal colonization factor. Proc. Natl. Acad. Sci. USA 90:3750-3754[Abstract/Free Full Text].
20. Rabbani, G. H., and W. B. Greenough. 1990. Cholera, p. 233-253. In E. Lebenthal, and M. Duffy (ed.), Text book of secretory diarrhea. Raven Press, New York, N.Y.
21. Sharma, C., G. B. Nair, A. K. Mukhopadhyay, S. K. Bhattacharya, R. K. Ghosh, and A. Ghosh. 1997. Molecular characterization of Vibrio cholerae O1 biotype El Tor strains isolated between 1992 and 1995 in Calcutta, India: evidence for the emergence of a new clone of the El Tor biotype. J. Infect. Dis. 175:1134-1141[Medline].
22. Southern, E. M. 1975. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J. Mol. Biol. 98:503-517[Medline].
23. Trucksis, M., J. E. Galen, J. Michalski, A. Fasano, and J. B. Kaper. 1993. Accessory cholera enterotoxin (Ace), the third toxin of a Vibrio cholerae virulence cassette. Proc. Natl. Acad. Sci. USA 90:5267-5271[Abstract/Free Full Text].
24. Waldor, M. K., and J. J. Mekalanos. 1996. Lysogenic conversion by a filamentous phage encoding cholera toxin. Science 272:1910-1914[Abstract].
25. Waldor, M. K., and J. J. Mekalanos. 1994. Emergence of a new cholera pandemic: molecular analysis of virulence determinants in Vibrio cholerae O139 and development of a live vaccine prototype. J. Infect. Dis. 170:278-283[Medline].
26. Waldor, M. K., E. J. Rubin, G. D. Pearson, H. Kimsey, and J. J. Mekalanos. 1997. Regulation, replication, and integration functions of the Vibrio cholerae CTXPhi are encoded by region RS2. Mol. Microbiol. 24:917-926[Medline].
27. World Health Organization. 1974. World Health Organization guidelines for the laboratory diagnosis of cholera. Bacterial Disease Unit, World Health Organization, Geneva, Switzerland.


Infect Immun, August 1998, p. 3752-3757, Vol. 66, No. 8
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Faruque, S. M.
Right arrow Articles by Mekalanos, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Faruque, S. M.
Right arrow Articles by Mekalanos, J. J.


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals